View source for Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 16.

{{#set:
|HasDocument=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
|RefScope=HM
|RefDocPart=Schedule 1
Part 2
16.
|RefLanguage=EN
|RefTagsEN=
|RefTagsOriginal=
|RefTagsFR=
}}

{{:Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004}}

{| class="gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Scope
| HM
|-
! Document part
| Schedule 1
Part 2
16.
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
| 
|-
! Tags (EN)
| 
|-
! Tags (original language)
| 
|-
! Tags (FR)
| 
|-
! Comment
| Indemnity and insurance provision requirements
|}

== Content ==
CONDITIONS AND PRINCIPLES WHICH APPLY TO ALL CLINICAL TRIALS
[…]
16.  Provision has been made for insurance or indemnity to cover the liability of the investigator and sponsor which may arise in relation to the clinical trial.